+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vitamin K2 Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 196 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016923
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Vitamin K2 market is entering a dynamic phase as innovations in ingredients, sourcing, and supply strategies redefine industry standards. Senior decision-makers ready to adapt quickly will navigate market changes and seize opportunities as consumer demand and regulatory frameworks swiftly evolve.

Market Snapshot: Vitamin K2 Market Size and Growth

The global Vitamin K2 market is experiencing significant expansion, with valuation rising from USD 423.56 million in 2024 to USD 458.41 million in 2025, and forecasts estimating a reach of USD 805.64 million by 2032. The compound annual growth rate during this timeframe is projected at 8.36%. Growth is driven by ongoing clinical support for Vitamin K2 efficacy, rising consumer prioritization of preventive health, and advancements in delivery technologies. Leading companies are leveraging encapsulation improvements to optimize bioavailability and reach broader audiences. Regional supply chain adjustments and regulatory shifts are also prompting firms to realign strategies across the nutraceutical landscape.

Scope & Segmentation of the Vitamin K2 Market

This report offers a structured examination of the Vitamin K2 market, enabling leaders to fine-tune strategic plans according to region and customer profile. The segmentation framework tracks demand trends and emerging use cases while mapping ecosystem changes relevant to regulatory and industry movement.

  • Form: Tracks the impact of Menaquinone-4 (MK-4) and Menaquinone-7 (MK-7), helping brands differentiate while focusing on enhanced functional benefits and efficacy.
  • Source: Evaluates the commercial flexibility of Natural and Synthetic sources, providing insights into supply assurance, compliance, and value messaging for established and emerging industry participants.
  • Dosage Form: Covers Capsule, Liquid, Powder, Softgel, and Tablet options, supporting both business and consumer-facing delivery strategies to broaden accessibility.
  • Purity Grade: Examines Feed Grade, Food Grade, and Pharmaceutical Grade variants to address varied end-use markets, from animal health to specialized medical use.
  • Application: Highlights Dietary Supplements, Functional Foods and Beverages, Personal Care, and Pharmaceuticals, demonstrating the sector’s ability to address multiple regulatory needs and user preferences.
  • Functional Foods and Beverages Sub-segments: Includes Bakery Products, Dairy Products, and Nutraceutical Drinks, underscoring opportunities in food fortification and added-value health alternatives.
  • Personal Care Sub-segments: Details Hair Care and Skincare Products, with Vitamin K2 applications expanding into topical and cosmeceutical markets.
  • Distribution Channel: Addresses Health Stores, Pharmacies, Supermarkets and Hypermarkets, Direct to Consumer Websites, and E-Commerce Platforms, covering diverse sales models for international reach.
  • Regions: Analyses the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting unique regulatory landscapes and adoption speeds that guide differentiated market entry and expansion.
  • Key Companies: Reviews leaders such as Koninklijke DSM N.V., BASF SE, Gnosis by Lesaffre S.p.A., Kappa Bioscience AS, Kyowa Hakko Bio Co., Ltd., CJ CheilJedang Corporation, NattoPharma AS, Dojin Chemical Co., Ltd., Kemin Industries, Inc., and Tianjin Zhongxin Pharmaceutical Group Corporation, with a focus on their roles in innovation, partnerships, and market positioning.

Key Takeaways for Senior Decision-Makers

  • Vitamin K2 is the foundation for tailored wellness offerings in mainstay and emerging health sectors, designed to match distinct consumer segments including bone and cardiovascular health.
  • Market leaders are prioritizing advances in both menaquinone variants and integrating robust clinical substantiation alongside formulation R&D to ensure enduring commercial relevance.
  • Transparent sourcing and supply visibility are increasingly pivotal, reflecting evolving global regulatory requirements and buyer demands for supply chain traceability.
  • Success by region aligns with high-performing healthcare infrastructures and supportive policy frameworks, enabling companies to optimize targeted launches and pilots.
  • Organizations are relying on proprietary manufacturing, research alliances, and adaptive distribution to reinforce operational flexibility across international markets.

Tariff Impact and Strategic Response

Recent US tariff changes beginning in 2025 have caused Vitamin K2 stakeholders to reevaluate import tactics, leading to diversified sourcing and supplier renegotiations. Senior executives are leveraging forward contracts and embracing vertical integration to stabilize pricing and strengthen supply chains despite regulatory dynamics. These approaches are consistent with a sector-wide emphasis on managing risk and enhancing long-term operational resilience.

Methodology & Data Sources

Findings in this Vitamin K2 market research report are developed through direct interviews with sector executives and academic experts, supported by thorough secondary research. Robust data triangulation and peer review ensure the validity and strategic value of insights provided to executive teams.

Why This Report Matters for the Vitamin K2 Market

  • Detailed segmentation and diverse regional insights help decision-makers identify primary growth segments and strategically allocate resources.
  • Analysis tracks the competitive impact of product and process innovation, guiding investment and partnership decisions for evolving market dynamics.
  • Regulatory and consumer trend monitoring prepares businesses to respond to new risks and capture opportunities arising from industry change.

Conclusion

Amid progress in technology and demand patterns, the Vitamin K2 market requires leadership focused on adaptability and targeted action. This report allows executives to capitalize on growth and navigate complex health and nutrition environments with confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of bioactive menaquinone-7 supplements for cardiovascular health support
5.2. Growing investment in fermentation-based vitamin K2 production to ensure sustainable scalability
5.3. Emergence of combined vitamin D3 and K2 formulations targeting bone density and immune function enhancement
5.4. Increasing partnerships between pharmaceutical companies and nutraceutical startups to develop novel K2 delivery formats
5.5. Surge in clinical research linking vitamin K2 supplementation to arterial plaque reduction and vascular health benefits
5.6. Development of plant-based vitamin K2 menaquinone-4 alternatives to cater to vegan consumer demand
5.7. Expansion of direct-to-consumer subscription services offering customized vitamin K2 dosing based on genetic profiling
5.8. Regulatory approvals and new health claims for vitamin K2 products in emerging Asian and European markets
5.9. Integration of microencapsulation technology to improve vitamin K2 stability and bioavailability in functional foods
5.10. Increasing awareness campaigns by professional medical associations highlighting the role of vitamin K2 in osteoporosis prevention
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Vitamin K2 Market, by Form
8.1. Menaquinone-4
8.2. Menaquinone-7
9. Vitamin K2 Market, by Source
9.1. Natural
9.2. Synthetic
10. Vitamin K2 Market, by Dosage Form
10.1. Capsule
10.2. Liquid
10.3. Powder
10.4. Softgel
10.5. Tablet
11. Vitamin K2 Market, by Purity Grade
11.1. Feed Grade
11.2. Food Grade
11.3. Pharmaceutical Grade
12. Vitamin K2 Market, by Application
12.1. Dietary Supplements
12.2. Functional Foods and Beverages
12.2.1. Bakery Products
12.2.2. Dairy Products
12.2.3. Nutraceutical Drinks
12.3. Personal Care
12.3.1. Hair Care Products
12.3.2. Skincare Products
12.4. Pharmaceuticals
13. Vitamin K2 Market, by Distribution Channel
13.1. Offline
13.1.1. Health Stores
13.1.2. Pharmacies
13.1.3. Supermarkets and Hypermarkets
13.2. Online
13.2.1. Direct To Consumer Websites
13.2.2. ECommerce Platforms
14. Vitamin K2 Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Vitamin K2 Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Vitamin K2 Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Koninklijke DSM N.V.
17.3.2. BASF SE
17.3.3. Gnosis by Lesaffre S.p.A.
17.3.4. Kappa Bioscience AS
17.3.5. Kyowa Hakko Bio Co., Ltd.
17.3.6. CJ CheilJedang Corporation
17.3.7. NattoPharma AS
17.3.8. Dojin Chemical Co., Ltd.
17.3.9. Kemin Industries, Inc.
17.3.10. Tianjin Zhongxin Pharmaceutical Group Corporation

Companies Mentioned

The companies profiled in this Vitamin K2 market report include:
  • Koninklijke DSM N.V.
  • BASF SE
  • Gnosis by Lesaffre S.p.A.
  • Kappa Bioscience AS
  • Kyowa Hakko Bio Co., Ltd.
  • CJ CheilJedang Corporation
  • NattoPharma AS
  • Dojin Chemical Co., Ltd.
  • Kemin Industries, Inc.
  • Tianjin Zhongxin Pharmaceutical Group Corporation

Table Information